Debate Erupts At WHO Over “Consensus” On Financing R&D For The Poor 28/01/2013 by William New, Intellectual Property Watch 5 Comments World Health Organization members on Friday held a tense discussion over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development for neglected diseases predominantly afflicting poor populations. The discussion may continue today, with the linkage of an agenda item on neglected tropical diseases and the report of an expert working group offering numerous ideas for addressing the problem.
WHO Plan For Pandemic Flu Proceeds With Questions 28/01/2013 by William New, Intellectual Property Watch 3 Comments The World Health Organization has not completed negotiations with companies on a formula for contribute toward the new WHO framework for pandemic influenza. But companies are paying to access the virus anyway. In its meeting this week, the WHO Executive Board has addressed a range of issues such as pandemic influenza, but so far it has delayed discussion on another contentious topic: substandard/counterfeit medical products.
Governments Put WHO’s Independence At Heart Of Reform Debate 25/01/2013 by Rachel Marusak Hermann, Intellectual Property Watch 2 Comments Any employee who has been through a company reform knows that it can be an anxious and stressful period. The experience is no different for the 194 members of the World Health Organization representing their respective countries and the public health interests of their constituents. As the WHO Executive Board digs deep into the fundamental principles of organisational change, preserving the holy member-driven nature of the global public health authority has emerged as the most pressing priority.
IP Professionals Discuss Tech Transfer Potential In Humanitarian Business At WIPO 23/01/2013 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment A global business association held a meeting at the World Intellectual Property Organization this week on IP market developments, including increasing opportunities in technology transfer for commercial purposes. The intimate gathering featured a line-up of high-level speakers, including WIPO Director General Francis Gurry.
US Trade Representative Ron Kirk To Depart In February 23/01/2013 by Intellectual Property Watch Leave a Comment United States Trade Representative Ron Kirk has announced his departure from office in late February.
UNITAID Seeks Bids For ‘Freedom To Operate’ IPR Analyses For HIV Products 22/01/2013 by Intellectual Property Watch Leave a Comment UNITAID, the drug purchasing facility affiliated with the World Health Organization, sees “great promise” in emerging diagnostic products for HIV treatment monitoring and diagnosis in remote regions. Now it is looking for someone to verify the freedom to operate of these tools, ensuring they are not intellectual property-encumbered.
2013: India Battles For Right To Use Compulsory Licences To Make Medicines Affordable 22/01/2013 by Patralekha Chatterjee for Intellectual Property Watch Leave a Comment India has started the New Year on a volatile note. With general elections looming in 2014, there is turbulence and not just in the political world. In India’s pharmaceutical industry, there is sparring over the prickly issue of ‘compulsory licenses’, a mechanism by which a government allows a domestic company to manufacture and sell a generic version of a patented drug without the consent of the patent-holder, who receives compensation.
Packed WHO Executive Board Agenda Highlights Need To Streamline Priorities 21/01/2013 by Rachel Marusak Hermann, Intellectual Property Watch 2 Comments World Health Organization Director General Margaret Chan today opened the 132nd meeting of the Executive Board, the UN agency’s highest authority, emphasising the importance of cost-effectiveness and results-driven operations at a time of global economic austerity and precarious funding.
US FTC Finds Sharp Rise In ‘Pay-For-Delay’ Deals Blocking Generics 18/01/2013 by William New, Intellectual Property Watch 2 Comments The United States Federal Trade Commission, which keeps an eye out for anticompetitive behaviour, has issued a study finding that in 2012, a record number of deals were struck between brand-name and generic drug companies to keep the lower-priced generics off the market. Such deals, which arise from patent disputes, cost American consumers billions of dollars annually while piling on the federal deficit, it said.
EPO Sees Record Patent Filings, Grants 18/01/2013 by Intellectual Property Watch 1 Comment The European Patent Office has announced that it reached new records in 2012 for patent filings and patents granted, according to preliminary figures. The United States remained at top, but growth was fastest in Asia, while European filings remained stable, it said.